| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23afbaf9885ffdfa029bf0f887ab502c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c0f8279e4f0639259bc21ccb484f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01cb73df79ef4adf928bce3f0b54297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d91e0be6fb21d47e7a7d5112ae54aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1d0c2a080aeb6713961953a3474cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edfe99d40cb01e052bc79e2520f94fdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_456360f5f3be909751218a8c180f6ea2 |
| publicationDate |
2019-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2681229-C1 |
| titleOfInvention |
Nucleotide sequence encoding the dbpag polypeptide, advantageous for serodiagnosis of lyme borreliosis, petdbpagnh recombinant plasmid dna, encoding dbpag combined polypeptide, recombinant bacteria strain escherichia coli bl21(de3)/petdbpagnh - producer of dbpag polypeptide, dbpag polypeptide and method for preparation thereof |
| abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to the field of biotechnology, specifically to the production of an immunogenic polypeptide that provides for the formation of an immune response against infection caused by spirochetes of the Borrelia burgdorferi sensu lato complex, and can be used for serodiagnosis of tick-borne borreliosis. Recombinantly, in cells of the E. coli BL21 (DE3)/pETdbpagNH strain of bacteria, a DBPAG fusion polypeptide consisting of the immunogenic domains of the Borrelia garinii and Borrelia afzelii DBPA proteins is obtained.EFFECT: invention provides a new polypeptide that is advantageous for the development of a new test system for the diagnosis of Lyme borreliosis.5 cl, 5 dwg, 2 tbl, 5 ex |
| priorityDate |
2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |